Trailing-twelve-month (TTM) revenue is $1.11 Billion with a year-over-year growth of +9.32%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-28 | $280,434,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-29 |
| Q3 FY2026Period ended 2025-12-28 | $244,080,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-28 |
| Q4 FY2026Period ended 2026-03-29 | $265,910,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-13 |
| Q1 FY2027Period ended 2026-06-28 | $315,675,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-29 |
| TTM revenue | $1,106,099,000 |
Current P/S: $2,760,734,223 market capitalization ÷ $1,106,099,000 TTM revenue = 2.50x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:01.000Z. Latest revenue period ended 2026-06-28.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-06-28): $315.68M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T22:27:12.073Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-29 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-28 · USD | FY20222022-04-03 · USD | FY20232023-04-02 · USD | FY20242024-03-31 · USD | FY20252025-03-30 · USD | FY20262026-03-29 · USD |
|---|---|---|---|---|---|---|
| Agricultural | N/A | N/A | N/A | N/A | N/A | $53M |
| Bulk | N/A | N/A |
$1.11B
$1.11 Billion
+9.32%
vs. $1.01B a year ago (TTM)
+11.74%
5 Year compound annual growth rate
1 Year
+9.32%
3 Year
+5.32%
5 Year
+11.74%
10 Year
+10.08%
15 Year
+9.00%
20 Year
+10.62%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $1.08B | +$109.27M | +11.21% |
| 2025 | $974.43M | +$55.27M | +6.01% |
| 2024 | $919.16M | ($15.94M) | (1.70%) |
| 2023 | $935.10M | +$160.56M | +20.73% |
| 2022 | $774.54M | +$177.67M | +29.77% |
| 2021 |
TTM Growth
+9.32%
3-Year CAGR
+5.32%
5-Year CAGR
+11.74%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T22:27:12.073Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $88M |
| $96M |
| $96M |
| Food | N/A | N/A | N/A | N/A | N/A | $99M |
|---|
| Health and Nutrition | $154M | $159M | N/A | N/A | N/A | N/A |
|---|
| Industrial | $273M | $387M | N/A | N/A | N/A | N/A |
|---|
| Nutrition | N/A | N/A | N/A | N/A | N/A | $138M |
|---|
| Other | N/A | N/A | $17M | $13M | $13M | $14M |
|---|
| Pharmaceutical | N/A | N/A | N/A | N/A | N/A | $28M |
|---|
| Water Treatment | $170M | $228M | N/A | N/A | N/A | N/A |
|---|
| $596.87M |
| +$56.67M |
| +10.49% |
| 2020 | $540.20M | ($16.13M) | (2.90%) |
| 2019 | $556.33M | +$52.16M | +10.35% |
| 2018 | $504.17M | +$20.58M | +4.25% |
| 2017 | $483.59M | +$69.62M | +16.82% |
